CLARISONIC PORE AND BLEMISH CLEANSER ACNE TREATMENT- salicylic acid gel

Clarisonic Pore and Blemish Cleanser Acne Treatment by

Drug Labeling and Warnings

Clarisonic Pore and Blemish Cleanser Acne Treatment by is a Otc medication manufactured, distributed, or labeled by Pacific Bioscience Laboratories, Inc., L'Oreal USA, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredient

Salicylic acid 2%

Purpose

Acne treatment

Uses

for the treatment of acne

Warnings

For external use only

When using this product

skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• apply directly to moistened skin or to a damp Clarisonic skin cleansing brush
• massage onto face, avoiding the eye area
• rinse thoroughly

Inactive ingredients

water, sodium laureth sulfate, decyl glucoside, glycerin, sodium chloride, coco-betaine, PEG-150 pentaerythrityl tetrastearate, PEG-6 caprylic/capric glycerides, zinc gluconate, sodium hydroxide, sodium benzoate, tetrasodium EDTA, capryloyl salicylic acid, citric acid, menthol, hexylene glycol, polyquaternium-47

Questions?

Call 1-888-525-2747

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

CLARISONIC PORE AND BLEMISH CLEANSER ACNE TREATMENT 
salicylic acid gel

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 69481-333
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	20 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
SODIUM LAURETH SULFATE (UNII: BPV390UAP0)
DECYL GLUCOSIDE (UNII: Z17H97EA6Y)
GLYCERIN (UNII: PDC6A3C0OX)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
COCO-BETAINE (UNII: 03DH2IZ3FY)
PEG-150 PENTAERYTHRITYL TETRASTEARATE (UNII: 8L4OOQ76AM)
PEG-6 CAPRYLIC/CAPRIC GLYCERIDES (UNII: GO50W2HWO8)
ZINC GLUCONATE (UNII: U6WSN5SQ1Z)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
SODIUM BENZOATE (UNII: OJ245FE5EU)
EDETATE SODIUM (UNII: MP1J8420LU)
CAPRYLOYL SALICYLIC ACID (UNII: 5F7PJF6AA4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
MENTHOL (UNII: L7T10EIP3A)
HEXYLENE GLYCOL (UNII: KEH0A3F75J)
POLYQUATERNIUM-47 (METHACRYLAMIDOPROPYLTRIMETHYLAMMONIUM CHLORIDE-CO-METHYL ACRYLATE-CO-ACRYLIC ACID 45:10:45; 1200000 MW) (UNII: F11YNO8FDQ)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 69481-333-01	120 mL in 1 TUBE; Type 0: Not a Combination Product	08/10/2017

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part333D	08/10/2017

Labeler - Pacific Bioscience Laboratories, Inc. (024874849)

Establishment
Name	Address	ID/FEI	Business Operations
L'Oreal USA, Inc.		185931458	manufacture(69481-333)